Bacteriophage-Based Vaccine Platform for Next Generation Vaccine Development Against Bovine Tuberculosis and Other Pulmonary Diseases of Animals

Aghebati-Maleki L, Bakhshinejad B, Baradaran B et al (2016) Phage display as a promising approach for vaccine development. J Biomed Sci 23:1–18. https://doi.org/10.1186/s12929-016-0226-5

Article  Google Scholar 

Alfaleh MA, Alsaab HO, Mahmoud AB et al (2020) Phage display derived monoclonal antibodies: from bench to bedside. Front Immunol 11:1986. https://doi.org/10.3389/fimmu.2020.01986

Article  CAS  PubMed  PubMed Central  Google Scholar 

An TQ, Tian ZJ, Xiao Y et al (2005) Identification of a B-cell epitope on the nucleocapsid protein of PRRSV using phage display. Virus Res 110:153–159

Google Scholar 

Bao Q, Li X, Han G, Zhu Y, Mao C, Yang M (2019) Phage-based vaccines. Adv Drug Deliv Rev 145:40–56

Article  CAS  PubMed  Google Scholar 

Benhar I (2001) Biotechnological applications of phage and cell display. Biotechnol Adv 19:1–33

Article  CAS  PubMed  Google Scholar 

Blanco FC, Marini MR, Klepp LI, Vazquez CL, Garcia EA, Bigi MM, Bigi F (2025) Long-term evaluation in BALBc mice of a triple mutant of Mycobacterium Bovis and the Bacillus Calmette-Guérin as potential vaccines against bovine tuberculosis. Vet Microbiol 302:110371

Article  CAS  PubMed  Google Scholar 

Cassioli C, Baldari CT (2022) The expanding arsenal of cytotoxic T cells. Front Immunol 13:883010. https://doi.org/10.3389/fimmu.2022.883010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castel G, Chtéoui M, Heyd B, Tordo N (2011) Phage display of combinatorial peptide libraries: application to antiviral research. Molecules 16:3499–3518

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Lovell S, Lee S, Fellner M, Mace PD, Bogyo M (2021) Identification of highly selective covalent inhibitors by phage display. Nat Biotechnol 39:490–498. https://doi.org/10.1038/s41587-020-00763-2

Article  CAS  PubMed  Google Scholar 

Dąbrowska K, Miernikiewicz P, Piotrowicz A et al (2014) Immunogenicity studies of proteins forming the T4 phage head surface. J Virol 88:12551–12557. https://doi.org/10.1128/JVI.02043-14

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falciani C, Lozzi L, Pini A, Bracci L (2005) Bioactive peptides from libraries. Chem Biol 12:417–426. https://doi.org/10.1016/j.chembiol.2005.02.009

Article  CAS  PubMed  Google Scholar 

Gale C, Velazquez E, Pattison E (2021) Mycoplasma hyopneumoniae as a causative agent of porcine enzootic pneumonia. Livestock 26(3):136–143

Article  Google Scholar 

Gao J, Wang Y, Liu Z, Wang Z (2010) Phage display and its application in vaccine design. Ann Microbiol 60:13–19. https://doi.org/10.1007/s13213-009-0003-7

Article  Google Scholar 

Golkar Z, Bagasra O, Pace DG (2014) Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. J Infect Dev Ctries 8:129–136. https://doi.org/10.3855/jidc.3573

Article  PubMed  Google Scholar 

Górski A, Weber-Dąbrowska B (2005) The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol Life Sci 62:511–519. https://doi.org/10.1007/s00018-004-4404-8

Article  PubMed  PubMed Central  Google Scholar 

Górski A, Dąbrowska K, Świtała-Jeleń K, Nowaczyk M, Weber-Dąbrowska B, Boratyński J, Wietrzyk J, Opolski A (2003) New insights into the possible role of bacteriophages in host defense and disease. Med Immunol 2:2. https://doi.org/10.1186/1476-9433-2-2

Article  PubMed  PubMed Central  Google Scholar 

Górski A, Międzybrodzki R, Borysowski J et al (2012) Phage as a modulator of immune responses: practical implications for phage therapy. Adv Virus Res 83:41–71. https://doi.org/10.1016/B978-0-12-394438-2.00002-5

Article  CAS  PubMed  Google Scholar 

Hangalapura BN, Witvliet M, Jacobs AAC, Segers RPAM (2025) A novel intradermal combination vaccine for PCV2 and Mycoplasma hyopneumoniae protection in swine: its use with Lawsonia intracellularis and PRRSV vaccines. Porc Health Manag 11(1):14. https://doi.org/10.1186/s40813-025-00426-9

Article  Google Scholar 

He L, Liu L, Zhou X, Hu Z, Shen J (2025) Visual counting of influenza A viruses with magnetic T4 phage SPR probe. ACS Sens 10(4):2928–2937

Article  CAS  PubMed  Google Scholar 

Hess KL, Jewell CM (2020) Phage display as a tool for vaccine and immunotherapy development. Bioeng Transl Med 5:e10142. https://doi.org/10.1002/btm2.10142

Article  PubMed  Google Scholar 

Hussain S, Khan S, Khan RU, Mohsin M, Khan A, Gamaryani A et al (2025) Innovations in poultry disease control: advancements in bacteriophage therapy and delivery systems. Pak Vet J. https://doi.org/10.29261/pakvetj/2025.213

Article  Google Scholar 

Irfan M, Khan MZ, Khan MA et al (2020) Isolation and species-specific identification of Mycobacterium Bovis from bovine Raw milk in Pakistan. Pak Vet J 40(1):155–158

Google Scholar 

Jaroszewicz W, Morcinek-Orłowska J, Pierzynowska K, Gaffke L, Węgrzyn G (2021) Phage display and other peptide display technologies. FEMS Microbiol Rev 46:fuab037. https://doi.org/10.1093/femsre/fuab037

Article  CAS  Google Scholar 

Jończyk E, Kłak M, Międzybrodzki R, Górski A (2011) The influence of external factors on bacteriophages. Folia Microbiol 56:191–200. https://doi.org/10.1007/s12223-011-0039-8

Article  CAS  Google Scholar 

Khan S, Ilyas N, Nawaz A, Khan MI, Aamir M, Khalid NA et al (2025b) Bacteriophage-based vaccination platform for antigen discovery and development of next-generation vaccines. Next Res 100776. https://doi.org/10.1016/j.nexres.2025.100776

Article  Google Scholar 

Kiss B, Kiss LA, Lohinai ZD, Mudra D, Tordai H, Herenyi L, Csík G, Kellermayer M (2022) Imaging the infection cycle of T7 at the single virion level. Int J Mol Sci 23:11252. https://doi.org/10.3390/ijms231911252

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krut O, Bekeredjian-Ding I (2018) Contribution of the immune response to phage therapy. J Immunol 200:3037–3044. https://doi.org/10.4049/jimmunol.1701745

Article  CAS  PubMed  Google Scholar 

Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11:69–86. https://doi.org/10.2174/138920110790725401

Article  CAS  PubMed  Google Scholar 

Letkiewicz S, Łusiak-Szelachowska M, Międzybrodzki R, Żaczek M, Weber-Dąbrowska B, Górski A (2021) Low immunogenicity of intravesical phage therapy for urogenitary tract infections. Antibiotics 10:627. https://doi.org/10.3390/antibiotics10060627

Article  PubMed  PubMed Central  Google Scholar 

Li Y, Zhang Y, Zhang X et al (2018) Phage display selection of peptides with high affinity for PRRSV GP4 protein and their antiviral activity. Antiviral Res 157:1–8

Article  Google Scholar 

Liu J, Zhang Q, Wang H et al (2005) Epitope mapping of Mycoplasma hyopneumoniae using phage display technology. Vet Microbiol 107:183–191

Google Scholar 

Łusiak-Szelachowska M, Międzybrodzki R, Rogoż P et al (2022) Do anti-phage antibodies persist after phage therapy? A preliminary report. Antibiotics 11:1358. https://doi.org/10.3390/antibiotics11101358

Article  PubMed  PubMed Central  Google Scholar 

Malys N, Chang D-Y, Baumann RG et al (2002) A bipartite bacteriophage T4 SOC and HOC randomized peptide display library: detection and analysis of phage T4 terminase (gp17) and late σ factor (gp55) interaction. J Mol Biol 319:289–304. https://doi.org/10.1016/s0022-2836(02)00298-x

Article 

Comments (0)

No login
gif